Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer

Published:2014-09 Issue:9 Volume:3 Page:e118-e118
ISSN:2157-9024
Container-title:Oncogenesis
language:en
Short-container-title:Oncogenesis

Author:

Lattanzio R, ,Ghasemi R,Brancati F,Sorda R L,Tinari N,Perracchio L,Iacobelli S,Mottolese M,Natali P G,Piantelli M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology

Link

http://www.nature.com/articles/oncsis201432.pdf

Reference32 articles.

1. Botha JL, Bray F, Sankila R, Parkin DM . Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003; 39: 1718–1729.

2. Cianfrocca M, Goldstein LJ . Prognostic and predictive factors in early-stage breast cancer. Oncologist 2004; 9: 606–616.

3. Peto R, Boreham J, Clarke M, Davies C, Beral V . UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000; 355: 1822.

4. Tyczynski JE, Bray F, Parkin DM . Breast cancer in Europe. ENCR Cancer Fact Sheets 2002; 2: 1–4.

5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687–1717.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cutting-edge 68Ga-labeled bicyclic peptide PET molecular probe for noninvasive assessment of Nectin4 expression;Bioorganic Chemistry;2024-11

2. Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study;Anticancer Research;2024-06-26

3. Therapeutic prospects of nectin-4 in cancer: applications and value;Frontiers in Oncology;2024-03-28

4. Antibody–drug conjugates in urothelial carcinoma: scientometric analysis and clinical trials analysis;Frontiers in Oncology;2024-03-14

5. Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4;Frontiers in Immunology;2024-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3